Erythema migrans: a chronicle

Area of Science:

• Medical Entomology
• Infectious Diseases
• Dermatology

Background:

• Erythema migrans (EM) was first described by Arvid Afzelius, who suspected a tick vector (Ixodes reduvius).
• Neurologic and cutaneous syndromes linked to EM were recognized in Europe in the early 20th century.
• Penicillin demonstrated effectiveness for treating EM in the mid-20th century.

Discussion:

• Lyme disease, identified in 1975 in Connecticut, shares cutaneous features with EM but involves cardiac, neurologic, and arthritic sequelae.
• The North American tick vector, Ixodes dammini, was identified in 1979, harboring agents for Lyme disease and babesiosis.
• The causative spirochete was named Borrelia burgdorferi.

Key Insights:

• Historical progression from EM description to Lyme disease recognition.
• Identification of the tick vector and causative agent (Borrelia burgdorferi).
• Distinction and relationship between EM and Lyme disease clinical presentations.

Outlook:

• Further research into North American and European Borrelia species.
• Understanding the diverse clinical syndromes associated with Borrelia burgdorferi.
• Continued investigation into tick-borne diseases and their sequelae.